3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
3
Status
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
CNS
3
Conditions
Brain Neoplasms
3
Xanthomatosis, Cerebrotendinous
1
Recurrence
1
Oligodendroglioma
1
Melanoma
1
Medulloblastoma
1
Influenza, Human
1
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Interventions
Temozolomide
38
Radiotherapy
22
Radiosurgery
22
Radiation
11
Magnetic Resonance Spectroscopy
11
Irinotecan
11
Cyclophosphamide
11
Etoposide
10
Surgical Procedures, Operative
9
Erlotinib Hydrochloride
9
Carmustine
9
pembrolizumab
8
Filgrastim
8
Carboplatin
8
Bevacizumab
7
Vincristine
6
Sorafenib
6
O(6)-benzylguanine
6
Nivolumab
6
Flucytosine
6
Aminolevulinic Acid
6
temsirolimus
5
sargramostim
5
Vorinostat
5
Trastuzumab
5
Topotecan
5
Lomustine
5
Imatinib Mesylate
5
Granulocyte Colony-Stimulating Factor
5
Everolimus
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 1
×
Brain Neoplasms
×
Diphtheria-Tetanus Vaccine
×
Clear all
NCT06254326
2026-05-27
ADAGiO
University of Florida
Phase 1
Recruiting
12 enrolled
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled
NCT02193347
2023-12-01
RESIST
Duke University
Phase 1
Completed
24 enrolled
8 charts